2943 related articles for article (PubMed ID: 7287588)
1. Antitumor activity of an antibiotic identical with or closely related to xanthomycin A.
Nishimura T; Kitajima J; Omura S; Tanaka N
J Antibiot (Tokyo); 1981 Jul; 34(7):856-61. PubMed ID: 7287588
[TBL] [Abstract][Full Text] [Related]
2. Studies on antineoplastic activity of naphthomycin, a naphthalenic ansamycin, and its mode of action.
Okabe T; Yuan BD; Isono F; Sato I; Fukazawa H; Nishimura T; Tanaka N
J Antibiot (Tokyo); 1985 Feb; 38(2):230-5. PubMed ID: 3997667
[TBL] [Abstract][Full Text] [Related]
3. [Study of new antineoplastic antibiotics based on newly discovered action mechanisms].
Tanaka N
Gan To Kagaku Ryoho; 1983 Apr; 10(4 Pt 2):1094-106. PubMed ID: 6191673
[TBL] [Abstract][Full Text] [Related]
4. Antitumor activity of a novel antitumor antibiotic, quinocarmycin citrate (KW2152).
Fujimoto K; Oka T; Morimoto M
Cancer Res; 1987 Mar; 47(6):1516-22. PubMed ID: 2434218
[TBL] [Abstract][Full Text] [Related]
5. BMY-28438 (3,7-dihydroxytropolone), a new antitumor antibiotic active against B16 melanoma. I. Production, isolation, structure and biological activity.
Sugawara K; Ohbayashi M; Shimizu K; Hatori M; Kamei H; Konishi M; Oki T; Kawaguchi H
J Antibiot (Tokyo); 1988 Jul; 41(7):862-8. PubMed ID: 3417559
[TBL] [Abstract][Full Text] [Related]
6. Experimental antitumor activity of BMY-28175 a new fermentation derived antitumor agent.
Schurig JE; Rose WC; Kamei H; Nishiyama Y; Bradner WT; Stringfellow DA
Invest New Drugs; 1990 Feb; 8(1):7-15. PubMed ID: 2345072
[TBL] [Abstract][Full Text] [Related]
7. Himastatin, a new antitumor antibiotic from Streptomyces hygroscopicus. I. Taxonomy of producing organism, fermentation and biological activity.
Lam KS; Hesler GA; Mattei JM; Mamber SW; Forenza S; Tomita K
J Antibiot (Tokyo); 1990 Aug; 43(8):956-60. PubMed ID: 2211362
[TBL] [Abstract][Full Text] [Related]
8. Sapurimycin, new antitumor antibiotic produced by Streptomyces. Producing organism, fermentation, isolation and biological properties.
Hara M; Takiguchi T; Ashizawa T; Gomi K; Nakano H
J Antibiot (Tokyo); 1991 Jan; 44(1):33-9. PubMed ID: 2001983
[TBL] [Abstract][Full Text] [Related]
9. Eponemycin, a new antibiotic active against B16 melanoma. I. Production, isolation, structure and biological activity.
Sugawara K; Hatori M; Nishiyama Y; Tomita K; Kamei H; Konishi M; Oki T
J Antibiot (Tokyo); 1990 Jan; 43(1):8-18. PubMed ID: 2106503
[TBL] [Abstract][Full Text] [Related]
10. Antitumor activity of spergualin, a novel antitumor antibiotic.
Nishikawa K; Shibasaki C; Takahashi K; Nakamura T; Takeuchi T; Umezawa H
J Antibiot (Tokyo); 1986 Oct; 39(10):1461-6. PubMed ID: 3781914
[TBL] [Abstract][Full Text] [Related]
11. Sultriecin, a new antifungal and antitumor antibiotic from Streptomyces roseiscleroticus. Production, isolation, structure and biological activity.
Ohkuma H; Naruse N; Nishiyama Y; Tsuno T; Hoshino Y; Sawada Y; Konishi M; Oki T
J Antibiot (Tokyo); 1992 Aug; 45(8):1239-49. PubMed ID: 1399844
[TBL] [Abstract][Full Text] [Related]
12. Gilvocarcins, new antitumor antibiotics. 3. Antitumor activity.
Morimoto M; Okubo S; Tomita F; Marumo H
J Antibiot (Tokyo); 1981 Jun; 34(6):701-7. PubMed ID: 6792176
[TBL] [Abstract][Full Text] [Related]
13. Tetrocarcins, new antitumor antibiotics. 3. Antitumor activity of tetrocarcin A.
Morimoto M; Fukui M; Ohkubo S; Tamaoki T; Tomita F
J Antibiot (Tokyo); 1982 Aug; 35(8):1033-7. PubMed ID: 7142004
[TBL] [Abstract][Full Text] [Related]
14. A new tetracycline antibiotic with antitumor activity. I. Taxonomy and fermentation of the producing strain, isolation and characterization of SF2575.
Hatsu M; Sasaki T; Watabe H; Miyadoh S; Nagasawa M; Shomura T; Sezaki M; Inouye S; Kondo S
J Antibiot (Tokyo); 1992 Mar; 45(3):320-4. PubMed ID: 1577660
[TBL] [Abstract][Full Text] [Related]
15. The biochemical pharmacology of CI-920, a structurally novel antibiotic with antileukemic activity.
Jackson RC; Fry DW; Boritzki TJ; Roberts BJ; Hook KE; Leopold WR
Adv Enzyme Regul; 1985; 23():193-215. PubMed ID: 3840949
[TBL] [Abstract][Full Text] [Related]
16. Antitumor activity and hematotoxicity of a new, substituted dihydrobenzoxazine, FK973, in mice.
Shimomura K; Manda T; Mukumoto S; Masuda K; Nakamura T; Mizota T; Matsumoto S; Nishigaki F; Oku T; Mori J
Cancer Res; 1988 Mar; 48(5):1166-72. PubMed ID: 3342397
[TBL] [Abstract][Full Text] [Related]
17. Azinomycins A and B, new antitumor antibiotics. III. Antitumor activity.
Ishizeki S; Ohtsuka M; Irinoda K; Kukita K; Nagaoka K; Nakashima T
J Antibiot (Tokyo); 1987 Jan; 40(1):60-5. PubMed ID: 3104267
[TBL] [Abstract][Full Text] [Related]
18. Biological and biochemical activities of the novel antitumor antibiotic PD 114,759 and related derivatives.
Fry DW; Shillis JL; Leopold WR
Invest New Drugs; 1986; 4(1):3-10. PubMed ID: 3754542
[TBL] [Abstract][Full Text] [Related]
19. Antitumor and cytocidal activities of a newly isolated benzenoid ansamycin, macbecin I.
Ono Y; Kozai Y; Ootsu K
Gan; 1982 Dec; 73(6):938-44. PubMed ID: 6186564
[TBL] [Abstract][Full Text] [Related]
20. A new antitumor antibiotic, FK973: its metabolism in the blood and the antitumor effects of its metabolites on experimental models.
Masuda K; Suzuki A; Nakamura T; Takagaki S; Noda K; Shimomura K; Noguchi H; Shibayama F
Jpn J Pharmacol; 1989 Oct; 51(2):219-26. PubMed ID: 2593379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
